Literature DB >> 23099416

Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.

Niels Hansen1, Benedikt Grünewald, Andreas Weishaupt, Maria Nandini Colaço, Klaus V Toyka, Claudia Sommer, Christian Geis.   

Abstract

Stiff person syndrome (SPS) is an autoimmune CNS disorder characterized by muscle rigidity, spasms and anxiety. The majority of patients have high-titer autoantibodies (ab) against glutamate decarboxylase (GAD65). A pathogenic role of SPS-associated IgG with ab against GAD65 has been shown for anxiety-like behavior but not for the core motor signs. We repetitively injected the purified IgG fraction of an SPS patient with severe motor impairment but without anxious comorbidity containing high titers of anti-GAD65 ab (SPS-IgG) into the lateral ventricle (i.c.v.) or intrathecally (i.th.) at the spinal level in experimental rats. We analyzed the effects on motor and anxiety-like behavior. Non-SPS human IgG fractions served as controls. Animals injected i.c.v. with SPS-IgG showed stiffness-like behavior with impaired walking ability and reduced grip strength of the upper limbs as well as postural and sensorimotor dysfunction. Testing for anxiety-like behavior revealed no significant differences between SPS and control IgG-treated rats. IgG deposits were found only in rats treated with SPS-IgG and were localized predominantly in CNS structures involved in motor control including globus pallidus, internal capsule, striatum and anterior thalamus. Double immunofluorescence staining revealed that predominantly GABAergic interneurons were positive for i.c.v. injected SPS-IgG. Rats injected i.th. with SPS-IgG did not present obvious motor symptoms and had a normal synaptic transmission at the spinal level. We conclude that SPS-like motor dysfunction can be induced in rats by passive transfer of IgG from an SPS-patient with high titer of anti-GAD65 ab. GABAergic dysfunction in supraspinal motor pathways rather than in the spinal cord may lead to motor deficits observed in the rats contrasting observations made in SPS with amphiphysin antibodies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23099416     DOI: 10.1016/j.expneurol.2012.10.013

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  33 in total

Review 1.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

2.  Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.

Authors:  C Geis
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 3.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.

Authors:  Josep Dalmau; Christian Geis; Francesc Graus
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

4.  'Moonlighting' surface antigens: a paradigm for autoantibody pathogenicity in neurology?

Authors:  Sarosh R Irani
Journal:  Brain       Date:  2016-02       Impact factor: 13.501

5.  Post-ganglionic autonomic neuropathy associated with anti-glutamic acid decarboxylase antibodies.

Authors:  E Fileccia; R Rinaldi; R Liguori; A Incensi; R D'Angelo; M P Giannoccaro; V Donadio
Journal:  Clin Auton Res       Date:  2016-12-02       Impact factor: 4.435

6.  Stiff person-syndrome IgG affects presynaptic GABAergic release mechanisms.

Authors:  Christian Werner; Holger Haselmann; Andreas Weishaupt; Klaus V Toyka; Claudia Sommer; Christian Geis
Journal:  J Neural Transm (Vienna)       Date:  2014-07-03       Impact factor: 3.575

7.  Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?

Authors:  Laura Lacruz Ballester; Mireya Fernandez-Fournier; Inmaculada Puertas Muñoz; Olaia Rodriguez Fraga; Clara Lastras Fernandez-Escandon; Francisco Javier Rodriguez de Rivera Garrido; Elda Maria Alba Suarez; Antonio Tallon Barranco
Journal:  Neurol Sci       Date:  2021-04-29       Impact factor: 3.307

Review 8.  GAD antibodies in neurological disorders - insights and challenges.

Authors:  Francesc Graus; Albert Saiz; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2020-05-26       Impact factor: 42.937

9.  Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.

Authors:  Thashi Chang; Haris Alexopoulos; Mary McMenamin; Alexander Carvajal-González; Sian K Alexander; Robert Deacon; Ferenc Erdelyi; Gabor Szabó; Szabó Gabor; Bethan Lang; Franz Blaes; Peter Brown; Angela Vincent
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

10.  Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats.

Authors:  Christiane S Hampe; Laura Petrosini; Paola De Bartolo; Paola Caporali; Debora Cutuli; Daniela Laricchiuta; Francesca Foti; Jared R Radtke; Veronika Vidova; Jérôme Honnorat; Mario Manto
Journal:  Orphanet J Rare Dis       Date:  2013-06-05       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.